Cystic Fibrosis(Mucoviscoidosis)Testing Market - Global Outlook and Forecast 2022-2028

March 2022 | 68 pages | ID: C4F51832228DEN
Market Monitor Global

Abstracts

Cystic Fibrosis, also known as mucoviscoidosis, is an inherited genetic disorder that affects the secretory glands, including mucus and sweat glands. It mainly affects the lungs and digestive system. An individual suffering from cystic fibrosis show characteristic symptoms, such as, secretion of thick and sticky mucus. The disease develops over a period of time in the lungs and blocks the tubes that carry air in and out. Increased secretion of thick mucus accelerates the growth of bacteria and hence, gives rise to serious lung infections. Some of the major symptoms of cystic fibrosis include persistent cough, constant lung infection, salty tasting skin, problem in breathing, bulky stools, difficulty in bowel movements, poor growth and poor weight gain. Some of the tests available for cystic fibrosis are newborn screening, sweat test, chest x-ray, lung function tests, and genetic testing. Cystic fibrosis can be divided into three segments, namely, cystic fibrosis mutations, curable type of cystic fibrosis, and rare type of cystic fibrosis. Some of the treatment methods for cystic fibrosis are chest physical therapy (CPT), exercise, consumption of antibiotics, lung transplant and postural drainage.

This report contains market size and forecasts of Cystic Fibrosis(Mucoviscoidosis)Testing in Global, including the following market information:

Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cystic Fibrosis(Mucoviscoidosis)Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Chest Physical Therapy (CPT) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cystic Fibrosis(Mucoviscoidosis)Testing include Vertex Pharmaceuticals, Abbott, Pfizer, NovaBiotics, Cystic Fibrosis Foundation and Galapagos, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cystic Fibrosis(Mucoviscoidosis)Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cystic Fibrosis(Mucoviscoidosis)Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Segment Percentages, by Type, 2021 (%)

• Chest Physical Therapy (CPT)
• Consumption Of Antibiotics
• Lung Transplant And Postural Drainage

Global Cystic Fibrosis(Mucoviscoidosis)Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Ambulatory Surgical Centers
• Others

Global Cystic Fibrosis(Mucoviscoidosis)Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cystic Fibrosis(Mucoviscoidosis)Testing revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cystic Fibrosis(Mucoviscoidosis)Testing revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Vertex Pharmaceuticals
• Abbott
• Pfizer
• NovaBiotics
• Cystic Fibrosis Foundation
• Galapagos

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cystic Fibrosis(Mucoviscoidosis)Testing Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CYSTIC FIBROSIS(MUCOVISCOIDOSIS)TESTING OVERALL MARKET SIZE

2.1 Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size: 2021 VS 2028
2.2 Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cystic Fibrosis(Mucoviscoidosis)Testing Players in Global Market
3.2 Top Global Cystic Fibrosis(Mucoviscoidosis)Testing Companies Ranked by Revenue
3.3 Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue by Companies
3.4 Top 3 and Top 5 Cystic Fibrosis(Mucoviscoidosis)Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cystic Fibrosis(Mucoviscoidosis)Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cystic Fibrosis(Mucoviscoidosis)Testing Players in Global Market
  3.6.1 List of Global Tier 1 Cystic Fibrosis(Mucoviscoidosis)Testing Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cystic Fibrosis(Mucoviscoidosis)Testing Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Markets, 2021 & 2028
  4.1.2 Chest Physical Therapy (CPT)
  4.1.3 Consumption Of Antibiotics
  4.1.4 Lung Transplant And Postural Drainage
4.2 By Type - Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue & Forecasts
  4.2.1 By Type - Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, 2017-2022
  4.2.2 By Type - Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, 2023-2028
  4.2.3 By Type - Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Ambulatory Surgical Centers
  5.1.4 Others
5.2 By Application - Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue & Forecasts
  5.2.1 By Application - Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, 2017-2022
  5.2.2 By Application - Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, 2023-2028
  5.2.3 By Application - Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size, 2021 & 2028
6.2 By Region - Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue & Forecasts
  6.2.1 By Region - Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, 2017-2022
  6.2.2 By Region - Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, 2023-2028
  6.2.3 By Region - Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, 2017-2028
  6.3.2 US Cystic Fibrosis(Mucoviscoidosis)Testing Market Size, 2017-2028
  6.3.3 Canada Cystic Fibrosis(Mucoviscoidosis)Testing Market Size, 2017-2028
  6.3.4 Mexico Cystic Fibrosis(Mucoviscoidosis)Testing Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, 2017-2028
  6.4.2 Germany Cystic Fibrosis(Mucoviscoidosis)Testing Market Size, 2017-2028
  6.4.3 France Cystic Fibrosis(Mucoviscoidosis)Testing Market Size, 2017-2028
  6.4.4 U.K. Cystic Fibrosis(Mucoviscoidosis)Testing Market Size, 2017-2028
  6.4.5 Italy Cystic Fibrosis(Mucoviscoidosis)Testing Market Size, 2017-2028
  6.4.6 Russia Cystic Fibrosis(Mucoviscoidosis)Testing Market Size, 2017-2028
  6.4.7 Nordic Countries Cystic Fibrosis(Mucoviscoidosis)Testing Market Size, 2017-2028
  6.4.8 Benelux Cystic Fibrosis(Mucoviscoidosis)Testing Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, 2017-2028
  6.5.2 China Cystic Fibrosis(Mucoviscoidosis)Testing Market Size, 2017-2028
  6.5.3 Japan Cystic Fibrosis(Mucoviscoidosis)Testing Market Size, 2017-2028
  6.5.4 South Korea Cystic Fibrosis(Mucoviscoidosis)Testing Market Size, 2017-2028
  6.5.5 Southeast Asia Cystic Fibrosis(Mucoviscoidosis)Testing Market Size, 2017-2028
  6.5.6 India Cystic Fibrosis(Mucoviscoidosis)Testing Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, 2017-2028
  6.6.2 Brazil Cystic Fibrosis(Mucoviscoidosis)Testing Market Size, 2017-2028
  6.6.3 Argentina Cystic Fibrosis(Mucoviscoidosis)Testing Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, 2017-2028
  6.7.2 Turkey Cystic Fibrosis(Mucoviscoidosis)Testing Market Size, 2017-2028
  6.7.3 Israel Cystic Fibrosis(Mucoviscoidosis)Testing Market Size, 2017-2028
  6.7.4 Saudi Arabia Cystic Fibrosis(Mucoviscoidosis)Testing Market Size, 2017-2028
  6.7.5 UAE Cystic Fibrosis(Mucoviscoidosis)Testing Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Vertex Pharmaceuticals
  7.1.1 Vertex Pharmaceuticals Corporate Summary
  7.1.2 Vertex Pharmaceuticals Business Overview
  7.1.3 Vertex Pharmaceuticals Cystic Fibrosis(Mucoviscoidosis)Testing Major Product Offerings
  7.1.4 Vertex Pharmaceuticals Cystic Fibrosis(Mucoviscoidosis)Testing Revenue in Global Market (2017-2022)
  7.1.5 Vertex Pharmaceuticals Key News
7.2 Abbott
  7.2.1 Abbott Corporate Summary
  7.2.2 Abbott Business Overview
  7.2.3 Abbott Cystic Fibrosis(Mucoviscoidosis)Testing Major Product Offerings
  7.2.4 Abbott Cystic Fibrosis(Mucoviscoidosis)Testing Revenue in Global Market (2017-2022)
  7.2.5 Abbott Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Cystic Fibrosis(Mucoviscoidosis)Testing Major Product Offerings
  7.3.4 Pfizer Cystic Fibrosis(Mucoviscoidosis)Testing Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Key News
7.4 NovaBiotics
  7.4.1 NovaBiotics Corporate Summary
  7.4.2 NovaBiotics Business Overview
  7.4.3 NovaBiotics Cystic Fibrosis(Mucoviscoidosis)Testing Major Product Offerings
  7.4.4 NovaBiotics Cystic Fibrosis(Mucoviscoidosis)Testing Revenue in Global Market (2017-2022)
  7.4.5 NovaBiotics Key News
7.5 Cystic Fibrosis Foundation
  7.5.1 Cystic Fibrosis Foundation Corporate Summary
  7.5.2 Cystic Fibrosis Foundation Business Overview
  7.5.3 Cystic Fibrosis Foundation Cystic Fibrosis(Mucoviscoidosis)Testing Major Product Offerings
  7.5.4 Cystic Fibrosis Foundation Cystic Fibrosis(Mucoviscoidosis)Testing Revenue in Global Market (2017-2022)
  7.5.5 Cystic Fibrosis Foundation Key News
7.6 Galapagos
  7.6.1 Galapagos Corporate Summary
  7.6.2 Galapagos Business Overview
  7.6.3 Galapagos Cystic Fibrosis(Mucoviscoidosis)Testing Major Product Offerings
  7.6.4 Galapagos Cystic Fibrosis(Mucoviscoidosis)Testing Revenue in Global Market (2017-2022)
  7.6.5 Galapagos Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cystic Fibrosis(Mucoviscoidosis)Testing Market Opportunities & Trends in Global Market
Table 2. Cystic Fibrosis(Mucoviscoidosis)Testing Market Drivers in Global Market
Table 3. Cystic Fibrosis(Mucoviscoidosis)Testing Market Restraints in Global Market
Table 4. Key Players of Cystic Fibrosis(Mucoviscoidosis)Testing in Global Market
Table 5. Top Cystic Fibrosis(Mucoviscoidosis)Testing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cystic Fibrosis(Mucoviscoidosis)Testing Product Type
Table 9. List of Global Tier 1 Cystic Fibrosis(Mucoviscoidosis)Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cystic Fibrosis(Mucoviscoidosis)Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cystic Fibrosis(Mucoviscoidosis)Testing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cystic Fibrosis(Mucoviscoidosis)Testing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cystic Fibrosis(Mucoviscoidosis)Testing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cystic Fibrosis(Mucoviscoidosis)Testing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2023-2028
Table 30. Vertex Pharmaceuticals Corporate Summary
Table 31. Vertex Pharmaceuticals Cystic Fibrosis(Mucoviscoidosis)Testing Product Offerings
Table 32. Vertex Pharmaceuticals Cystic Fibrosis(Mucoviscoidosis)Testing Revenue (US$, Mn), (2017-2022)
Table 33. Abbott Corporate Summary
Table 34. Abbott Cystic Fibrosis(Mucoviscoidosis)Testing Product Offerings
Table 35. Abbott Cystic Fibrosis(Mucoviscoidosis)Testing Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Cystic Fibrosis(Mucoviscoidosis)Testing Product Offerings
Table 38. Pfizer Cystic Fibrosis(Mucoviscoidosis)Testing Revenue (US$, Mn), (2017-2022)
Table 39. NovaBiotics Corporate Summary
Table 40. NovaBiotics Cystic Fibrosis(Mucoviscoidosis)Testing Product Offerings
Table 41. NovaBiotics Cystic Fibrosis(Mucoviscoidosis)Testing Revenue (US$, Mn), (2017-2022)
Table 42. Cystic Fibrosis Foundation Corporate Summary
Table 43. Cystic Fibrosis Foundation Cystic Fibrosis(Mucoviscoidosis)Testing Product Offerings
Table 44. Cystic Fibrosis Foundation Cystic Fibrosis(Mucoviscoidosis)Testing Revenue (US$, Mn), (2017-2022)
Table 45. Galapagos Corporate Summary
Table 46. Galapagos Cystic Fibrosis(Mucoviscoidosis)Testing Product Offerings
Table 47. Galapagos Cystic Fibrosis(Mucoviscoidosis)Testing Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cystic Fibrosis(Mucoviscoidosis)Testing Segment by Type in 2021
Figure 2. Cystic Fibrosis(Mucoviscoidosis)Testing Segment by Application in 2021
Figure 3. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cystic Fibrosis(Mucoviscoidosis)Testing Revenue in 2021
Figure 8. By Type - Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cystic Fibrosis(Mucoviscoidosis)Testing Revenue Market Share, 2017-2028
Figure 12. US Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cystic Fibrosis(Mucoviscoidosis)Testing Revenue Market Share, 2017-2028
Figure 16. Germany Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2017-2028
Figure 17. France Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cystic Fibrosis(Mucoviscoidosis)Testing Revenue Market Share, 2017-2028
Figure 24. China Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2017-2028
Figure 28. India Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cystic Fibrosis(Mucoviscoidosis)Testing Revenue Market Share, 2017-2028
Figure 30. Brazil Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cystic Fibrosis(Mucoviscoidosis)Testing Revenue Market Share, 2017-2028
Figure 33. Turkey Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cystic Fibrosis(Mucoviscoidosis)Testing Revenue, (US$, Mn), 2017-2028
Figure 37. Vertex Pharmaceuticals Cystic Fibrosis(Mucoviscoidosis)Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbott Cystic Fibrosis(Mucoviscoidosis)Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Cystic Fibrosis(Mucoviscoidosis)Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. NovaBiotics Cystic Fibrosis(Mucoviscoidosis)Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Cystic Fibrosis Foundation Cystic Fibrosis(Mucoviscoidosis)Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Galapagos Cystic Fibrosis(Mucoviscoidosis)Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)